<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
87752-002-01
</NDCCode>
<PackageDescription>
227 g in 1 JAR (87752-002-01)
</PackageDescription>
<NDC11Code>
87752-0002-01
</NDC11Code>
<ProductNDC>
87752-002
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Nervionoix Pro Neuropathy Fast Acting Cream
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Lidocaine Hydrochloride, Menthol,magnesium Chloride
</NonProprietaryName>
<DosageFormName>
CREAM
</DosageFormName>
<RouteName>
TOPICAL
</RouteName>
<StartMarketingDate>
20260603
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
UNAPPROVED DRUG OTHER
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Micelle Laboratories, Incorporated
</LabelerName>
<SubstanceName>
LIDOCAINE HYDROCHLORIDE; MAGNESIUM CHLORIDE; MENTHOL
</SubstanceName>
<StrengthNumber>
1; 2; 3.7
</StrengthNumber>
<StrengthUnit>
g/100g; g/100g; g/100g
</StrengthUnit>
<Pharm_Classes>
Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Local Anesthesia [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2026-06-26
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20260603
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>